# Amiloride for Resistant Hypertension

> **NCT02122731** · PHASE4 · COMPLETED · sponsor: **Ib Abildgaard Jacobsen** · enrollment: 80 (actual)

## Conditions studied

- Hypertension
- Type 2 Diabetes Mellitus
- Microalbuminuria

## Interventions

- **DRUG:** Amiloride

## Key facts

- **NCT ID:** NCT02122731
- **Lead sponsor:** Ib Abildgaard Jacobsen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02122731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02122731, "Amiloride for Resistant Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02122731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*